Table 3 Comparison of antimicrobial therapies prescribed in the empirical and the rm-PCR-guided groups (n = 159)
Antibiotic treatment | Routine empirical therapy (%) | rm-PCR-guided therapy (%) |
|---|---|---|
Beta-lactams | 147 (92) | 131 (82) |
Third-generation cephalosporin | 35 (22) | 24 (15) |
Piperacillin-tazobactam | 29 (18) | 34 (21) |
Amoxicillin-clavulanate | 27 (17) | 25 (16) |
Carbapenem | 27 (17) | 19 (12) |
Cefepime | 19 (12) | 19 (12) |
Amoxicillin | 5 (3) | 4 (3) |
Ceftazidime | 3 (2) | 7 (4) |
Cefazolin | 2 (1) | 6 (4) |
Penicillin M | 0 (0) | 2 (1) |
Companion molecule | 79 (50) | 50 (31) |
Macrolide | 20 (13) | 4 (3) |
Metronidazole | 17 (11) | 8 (5) |
Aminoglycoside | 15 (9) | 19 (12) |
Fluoroquinolone | 8 (5) | 5 (3) |
Glycopeptide | 6 (4) | 2 (1) |
Linezolide | 6 (4) | 8 (5) |
Cotrimoxazole | 7 (4) | 4 (3) |
Antifungal therapy | 5 (3) | 4 (3) |
Oseltamivir | 3 (2) | 0 |
Other | 4 (3) | 0 |